A Phase 2 Study To Assess Olaparib By Homologous Recombination Deficiency Status In Patients With Platinum-Sensitive, Relapsed, Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer.
JOURNAL OF CLINICAL ONCOLOGY（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要